integrin inhibitor (St Louis University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameintegrin inhibitor (St Louis University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin antagonistsTransforming growth factor beta 1 modulators
TargetsIntegrinTransforming growth factor beta 1
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSaint Louis University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSaint Louis University
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A